Guanosine 5'-monophosphate

Mechanism of Action: Guanosine 5'-monophosphate can support studies connecting nucleotide metabolism with protein turnover, stress adaptation, and proteostasis regulation. Customers may use it to examine how guanine nucleotide pools influence signaling pathways, RNA-associated processes, and cellular conditions that affect degradation-related protein stability.

• Nucleotidic Ligand Recruitment: Guanosine 5'-monophosphate can serve as a small-molecule warhead or binding motif in PROTAC designs targeting nucleotide-binding proteins. In degradation workflows, it may be leveraged to position an E3 ligase recruiter for proximity-driven ubiquitination, enabling selective removal of the target in proteome-wide studies.

• cGMP Pathway Targeting: As a guanine nucleotide analog, Guanosine 5'-monophosphate can be used to explore PROTAC-mediated degradation of proteins that recognize guanosine phosphates. Researchers can test whether coupling this ligand to an E3 ligase ligand yields efficient target engagement, ubiquitination, and functional knockdown in cell-based degradation assays.

• ATP-Binding Site Probing: The phosphate-bearing guanine scaffold is useful for PROTAC discovery aimed at proteins with nucleotide-binding pockets. By attaching Guanosine 5'-monophosphate to a chimeric framework, investigators can evaluate whether induced proximity promotes productive ternary complex formation and downstream proteasomal degradation.

• Signal-Dependent Degradation Studies: Guanosine 5'-monophosphate–based PROTACs can support experiments examining how nucleotide availability or signaling state influences degradation efficiency. This approach enables mechanistic studies of ternary complex stability, residence time, and ubiquitin recruitment under controlled biochemical conditions.

• Proteome-Wide Target Discovery: In ligand-guided PROTAC development, Guanosine 5'-monophosphate can help identify previously uncharacterized nucleotide-interacting targets. Coupling it to an E3 ligase recruiter and screening degradation readouts (e.g., immunoblotting or proteomics) can reveal candidate proteins for subsequent optimization and mechanistic validation.

Structure: The structure of Guanosine 5'-monophosphate is characterized by primary or secondary amine/basic nitrogen centers; phenol or alcohol functionality. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.